Pharmas & social media policy: “it’s fairly urgent”
The FDA regards social media as an advertising tool for the pharma industry, which means that any company that doesn’t have a social media policy in place, or has a policy deemed insufficient, puts itself (and the public) at potential risk, says Attorney Anand Agneshwar.
“The FDA likely will address adverse event reporting in the social media guidance it will shortly issue“…
How urgent is it that companies institute social media policies?
“In this rapidly evolving area, it’s fairly urgent. Company professionals may be active on LinkedIn, employees may discuss company products—or their managers—on blogs, and whistleblowers undoubtedly will look to the Internet. Companies must have carefully thought-through policies to manage these and other eventualities“.
Sirk, Kimberly. Drawing the web tighter. Drug Discovery News, March 2011. pp. 40-41.